Skip to main content
logo
Artiva Biotherapeutics, Inc. (ARTV)
NASDAQ: ARTV · Real-Time Price · USD
11.59
+0.52 (4.70%)
At close: Aug 5, 2026, 4:00 PM EDT
11.73
+0.14 (1.17%)
After-hours: Aug 5, 2026, 7:34 PM EDT

Artiva Biotherapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
--0.2533.494.932
Revenue Growth
---99.25%579.21%146.30%-
Gross Profit
--0.2533.494.932
Operating Income
-92.07-89.81-67.28-30.67-59.83-53.27
Net Income
-87.07-83.87-65.37-28.72-58.79-34.72
Earnings Per Share
-3.54-3.43-5.81-35.7876.67-104.74
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash (Debt)
86.78108.01185.4376.97102.53160.92
Net Cash Growth
-47.71%-41.75%140.91%-24.93%-36.29%532.51%
Cash & Investments
86.78108.01185.4376.97102.53160.92
Net Cash Per Share
3.544.4216.4795.88133.73234.64

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-77.86-76.75-55.03-47.43-50.83-15.3
Capital Expenditures
-2.32-2.59-0.64-3.26-6.3-1.72
Free Cash Flow
-80.18-79.34-55.67-50.69-57.13-17.03
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
--100.00%100.00%100.00%100.00%
Operating Margin
---26805.60%-91.58%-1213.32%-2660.94%
Pretax Margin
---26045.02%-85.54%-1191.14%-1734.22%
Profit Margin
---26045.00%-85.75%-1192.21%-1734.22%
FCF Margin
---22180.90%-151.34%-1158.55%-850.55%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
--975.54---